Maker of Much-Debated ALS Drug Contemplates Ceasing Sales Following Study Showing Ineffectiveness
Breakthroughs and controversies often mark the landscape of pharmaceuticals, and the story of ALS (Amyotrophic Lateral Sclerosis) treatment is no exception. Recently, the maker of a drug long-debated for its….